Tirzepatide should be discontinued before trying to conceive, with manufacturers recommending a washout period of at least one month prior to planned pregnancy. That said, the weight loss tirzepatide provides may actually boost fertility for patients with obesity-related reproductive challenges, including those with PCOS. The relationship between tirzepatide and fertility requires careful planning with your provider.

As tirzepatide prescriptions have surged for both diabetes and weight management, questions about its effects on reproductive health have become increasingly common. Women of childbearing age make up a significant share of patients using this medication, making fertility considerations essential to discuss early in treatment.

Why Tirzepatide Must Be Stopped Before Pregnancy

Tirzepatide has a half-life of approximately five days, meaning it takes several weeks to fully clear from your body after the last injection. The prescribing information for both Mounjaro and Zepbound recommends stopping tirzepatide at least one month before a planned pregnancy.

Animal studies at doses exceeding human therapeutic levels showed evidence of adverse developmental effects, including skeletal abnormalities and reduced fetal growth. While human pregnancy data is extremely limited, the precautionary recommendation is to ensure the drug is fully cleared before conception.

How Weight Loss From Tirzepatide Can Improve Fertility

Obesity is a well-established barrier to fertility in both women and men. Excess body fat disrupts hormone production, ovulation patterns, and sperm quality. Even a 5% to 10% reduction in body weight can meaningfully improve reproductive outcomes.

For women, weight loss on tirzepatide can:

• Restore regular ovulatory cycles, especially in patients with PCOS
• Improve responsiveness to fertility treatments like IVF and IUI
• Reduce levels of excess estrogen produced by fat tissue
• Lower the risk of pregnancy complications such as gestational diabetes

For men, weight reduction can raise testosterone levels and improve sperm concentration, motility, and morphology. Some fertility specialists now recommend a structured weight loss phase with medications like tirzepatide before beginning fertility treatment, followed by a proper washout period.

Tirzepatide, PCOS, and Unexpected Ovulation

Polycystic ovary syndrome affects roughly 8% to 13% of women of reproductive age. Many patients with PCOS experience irregular or absent ovulation, which is a primary cause of PCOS-related infertility. Because tirzepatide improves insulin sensitivity and promotes weight loss, it may help restore ovulation in women who had previously stopped ovulating regularly.

This return of ovulation can catch patients off guard. Some women who believed they were unable to conceive have become pregnant unexpectedly while on tirzepatide or similar GLP-1 medications. If you do not want to become pregnant, use reliable contraception throughout your treatment. tirzepatide and PCOS

Contraception While on Tirzepatide

Tirzepatide slows gastric emptying, which raises a theoretical concern about reduced absorption of oral contraceptive pills. The prescribing information notes this possibility and recommends that patients using oral hormonal contraceptives either switch to a non-oral method or add a backup method (such as condoms) for four weeks after starting tirzepatide and for four weeks after each dose increase.

Non-oral methods such as IUDs, implants, patches, and injections are not affected by gastric emptying changes and may be more reliable options during tirzepatide treatment.

Frequently Asked Questions